Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
AstraZeneca
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Minimum of 3 months history of asthma, diagnosed according to the American Thoracic Society (ATS) definition (9).
Prescribed inhaled GCS at a dose of 400μg/day of budesonide (or equivalents)and within the approved label for the relevant drug during the last 3 months prior to Visit 1.
Either daily maintenance treatment with both inhaled GCS and LABA or daily treatment with inhaled GCS alone (i.e. without LABA)
A history of suboptimal asthma control the month prior to enrolment as judged by the investigator
Use of ≥3 inhalations of as needed medication for symptom relief during the last 7 days before enrolment
You may not be if
Previous treatment with Symbicort Single Inhaler;
Use of any b-blocking agent, including eye-drops and oral GCS as maintenance treatment.
Known or suspected hypersensitivity to study therapy or excipients.
A history of smoking ≥ 10 pack years.
Asthma exacerbation requiring change in asthma treatment during the last 14 days prior to or at Visit 1.
Clareo Health | Symbicort Single Inhaler Therapy vs Conventional Best Practice for the Treatment of Persistent Asthma in Adults
